Postoperative effective analgesia in hip replacement surgery
Phase 4
- Conditions
- Health Condition 1: M169- Osteoarthritis of hip, unspecifiedHealth Condition 2: M056- Rheumatoid arthritis with involvement of other organs and systemsHealth Condition 3: M138- Other specified arthritisHealth Condition 4: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2024/04/065080
- Lead Sponsor
- Dr VINOTHKUMAR V
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients with Osteoarthritis Hip
Rheumatoid Arthritis Hip
Avascular Necrosis of Hip
Traumatic Arthritis Hip
ASA Class One Two and Three
Patient Oriented to Give Consent.
Exclusion Criteria
PATIENT REFUSAL
ASA FOUR AND FIVE
PATIENTS WITH BLEEDING DIATHESIS
CHRONIC USE OF OPIOIDS
PATIENT NOT ABLE TO GIVE INFORMED CONSENT
KNOWN HYPERSENSITIVITY TO LOCAL ANAESTHETIC DRUGS
PATIENTS LESS THAN 18YRS AND MORE THAN 65YRS
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual Analogue ScaleTimepoint: Quality of Analgesia assessed by VAS Score at 30mins,1hour,2hours,3hours,4hours,5hours,6hours,8th hour,10th hour,12th hour,18th hour,24th hour after Nerve Block Administration.
- Secondary Outcome Measures
Name Time Method Hemodynamic parametersTimepoint: After Nerve Block Administration at 30mins,1Hour,2hours,3hours,4hours,5hours,6hours,8th hour,10th hour,12th hour,18th hour,24Hours.